These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10917687)

  • 1. Immunological investigations following an adverse reaction to oxybuprocaine eye drops.
    Sewell WA; Croucher JJ; Bird AG
    Br J Ophthalmol; 1999 May; 83(5):632. PubMed ID: 10917687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oxybuprocaine drops and eyedrops should not be given to patientson prescription].
    Cruysberg JR
    Ned Tijdschr Geneeskd; 1990 Sep; 134(39):1910. PubMed ID: 2215773
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxybuprocaine keratopathy: a preventable disease.
    Penna EP; Tabbara KF
    Br J Ophthalmol; 1986 Mar; 70(3):202-4. PubMed ID: 3954977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal thickness values before and after oxybuprocaine 0.4% eye drops.
    Asensio I; Rahhal SM; Alonso L; Palanca-Sanfrancisco JM; Sanchis-Gimeno JA
    Cornea; 2003 Aug; 22(6):527-32. PubMed ID: 12883345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Particularly rapid appearance of a severe toxic keratopathy caused by oxybuprocaine].
    Jallet G; Cleirens S; Girard E; Béchetoille A
    Bull Soc Ophtalmol Fr; 1980; 80(4-5):385-7. PubMed ID: 7460172
    [No Abstract]   [Full Text] [Related]  

  • 6. Corneal thickness differences between sexes after oxybuprocaine eye drops.
    Fernandez-Garcia P; Cerviño A; Quiles-Guiñau L; Albarran-Diego C; Garcia-Lazaro S; Sanchis-Gimeno JA
    Optom Vis Sci; 2015 Jan; 92(1):89-94. PubMed ID: 25360701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradycardia as a side-effect to oxybuprocaine.
    Christensen C
    Acta Anaesthesiol Scand; 1990 Feb; 34(2):165-6. PubMed ID: 2305619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs.
    Douet JY; Michel J; Regnier A
    Am J Vet Res; 2013 Oct; 74(10):1321-6. PubMed ID: 24066916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oxybuprocaine eye drops on corneal volume and thickness measurements.
    Rosa N; De Bernardo M; Borrelli M; Filosa ML; Lanza M
    Optom Vis Sci; 2011 May; 88(5):640-4. PubMed ID: 21358446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome.
    Ansari H; Weinberg L; Spencer N
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24038291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinous iritis due to oxybuprocaine.
    Haddad R
    Br J Ophthalmol; 1989 Jan; 73(1):76-7. PubMed ID: 2920158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxybuprocaine induces a false positive.
    Uchio E; Kadonosono K; Aoki K; Ohno S
    Ophthalmology; 2004 Aug; 111(8):1618. PubMed ID: 15288997
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic keratopathy associated with abuse of low-dose anesthetic: a case report.
    Chen HT; Chen KH; Hsu WM
    Cornea; 2004 Jul; 23(5):527-9. PubMed ID: 15220742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misuse of topical ocular anesthetics.
    Hagan JC
    Mo Med; 1981 Apr; 78(4):191-2. PubMed ID: 7254170
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic pharmaceutical agents: side effects encountered in a study of 15,000 applications.
    Yolton DP; Kandel JS; Yolton RL
    J Am Optom Assoc; 1980 Feb; 51(2):113-8. PubMed ID: 6768788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-preserved 1% lidocaine solution has less antibacterial properties than currently available anaesthetic eye-drops.
    Labetoulle M; Frau E; Offret H; Nordmann P; Naas T
    Curr Eye Res; 2002 Aug; 25(2):91-7. PubMed ID: 12525962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal anesthesia following application of 0.4% oxybuprocaine hydrochloride ophthalmic solution to normal feline eyes.
    Giudici V; Baeza S; Douet JY; Regnier A
    Vet Ophthalmol; 2015 Mar; 18(2):141-6. PubMed ID: 24824864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical anaesthetics and repeated tonometry on intraocular pressure.
    Jóhannesson G; Hallberg P; Eklund A; Behndig A; Lindén C
    Acta Ophthalmol; 2014 Mar; 92(2):111-5. PubMed ID: 23387522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degree of corneal anesthesia after topical application of 0.4% oxybuprocaine ophthalmic solution in normal equids.
    Little E; Yvorchuk-St Jean K; Little W; Sithole F; St Jean G
    Can J Vet Res; 2016 Oct; 80(4):329-334. PubMed ID: 27733789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dangers of eye drops.
    Bellows JG
    N Engl J Med; 1968 Oct; 279(16):890. PubMed ID: 5677732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.